Profiles of studies on XXXX included in the systematic literature review Authors Study design/ Level of Location Study population Description of Description of Relevant outcomes Measurement of duration evidencea characteristics Intervention Comparator assessed outcomes and ID Setting and risk of methods of analysis Eg N, age, gender, <including duration of <including duration of (ie related to Publication Length of bias disease treatment> treatment> outcomes specified in Year follow-up assessmentb description and PICO) severity, baseline function <study design characteristics such as CC=case control; Coh=cohort; CS=case series; DB=double blind; MC=multi-centre; NR=non-randomised; OL=open label (unblinded); R=randomised; SB=single blind; X=cross-sectional etc> ; a source: see NHMRC hierarchy of evidence b risk of bias as it relates to primary outcomes of the systematic review
Profiles of studies on XXXX included in the systematic literature review Authors ID Publication Year Study design/ duration Level of evidencea and risk of bias assessmentb Location Setting Length of follow-up Study population characteristics Eg N, age, gender, disease description and severity, baseline function Description of Intervention <including duration of treatment> Description of Comparator <including duration of treatment> Relevant outcomes assessed (ie related to outcomes specified in PICO) Measurement of outcomes and methods of analysis <study design characteristics such as CC=case control; Coh=cohort; CS=case series; DB=double blind; MC=multi-centre; NR=non-randomised; OL=open label (unblinded); R=randomised; SB=single blind; X=cross-sectional etc> a source: see NHMRC hierarchy of evidence ; b risk of bias as it relates to primary outcomes of the systematic review
MSAC%20SBA%20or%20CA%20Assessment%20Report%20Template%20-Therapeutic.docx